These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 13374137)

  • 1. [Hypnotic effect of 3-phenyl-3-ethyl-glutarimide. I. Possibility of synergistic action].
    CASENTINI S; MARIANI L
    Boll Soc Ital Biol Sper; 1956 Jun; 32(6):487-9. PubMed ID: 13374137
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypnotic effect of 3-phenyl-3-ethyl-glutarimide. II. Possibility of antagonistic action].
    CASENTINI S; MARIANI L
    Boll Soc Ital Biol Sper; 1956 Jun; 32(6):490-1. PubMed ID: 13374138
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of alpha-ethyl-alpha-phenyl-glutarimide (Doriden) as a motion sickness preventive.
    TYLER DB
    Curr Ther Res Clin Exp; 1961 Jun; 3():250-4. PubMed ID: 13778867
    [No Abstract]   [Full Text] [Related]  

  • 4. An electro-encephalographic study of the analeptic action of beta beta ethyl methyl glutarimide (megimide). I. Against several barbiturates and other hypnotics. II. Compared with other analeptics and convulsants.
    CASS NM
    Br J Anaesth; 1956 Jul; 28(7):324-35. PubMed ID: 13342310
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical evaluation of methyprylon (noludar) as a preanaesthetic sedative hypnotic.
    DOBKIN AB; WYANT GM
    Can Anaesth Soc J; 1957 Jan; 4(1):27-36. PubMed ID: 13396638
    [No Abstract]   [Full Text] [Related]  

  • 6. Noludar, a useful sedative-hypnotic drug.
    RADNAY PA
    Postgrad Med; 1957 Jun; 21(6):617-23. PubMed ID: 13431587
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experiences with methyprylon, a nonbarbiturate sedative and hypnotic drug.
    BILLOW BW; STEINBERG M; LUPINI SB; ROTHMAN H; CAREY R; PALEY SS; MARTORELLA FJ
    Int Rec Med; 1960 May; 173():288-92. PubMed ID: 13800724
    [No Abstract]   [Full Text] [Related]  

  • 8. A new, mild sedative-hypnotic, a piperidine derivative (noludar).
    BRANDMAN O; CONIARIS J; KELLER HE
    J Med Soc N J; 1955 May; 52(5):246-53. PubMed ID: 14368200
    [No Abstract]   [Full Text] [Related]  

  • 9. Methyprylon, a new sedative and hypnotic drug.
    CASS LJ; FREDERIK WS; ANDOSCA JB
    N Engl J Med; 1955 Oct; 253(14):586-91. PubMed ID: 13266000
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trial of methyprylone, a piperidine hypnotic.
    STEWART JS
    Br Med J; 1956 Dec; 2(5007):1465-7. PubMed ID: 13374358
    [No Abstract]   [Full Text] [Related]  

  • 11. [ON METHYPRYLON ADDICTION; A CONTRIBUTION OF HYPNOTIC ADDICTION].
    NEUMANN H; JANSSEN D
    Med Klin; 1964 Nov; 59():1829-31. PubMed ID: 14330836
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experiences with a barbiturate-free hypnotic and sedative in small children. Clinical and electroencephalographic research on 2,4-dioxo-3,3-diethyl-5-methylpiperidine (Noludar)].
    HORSTMANN W
    Munch Med Wochenschr; 1962 Mar; 104():603-8. PubMed ID: 14449058
    [No Abstract]   [Full Text] [Related]  

  • 13. Glutethimide, a new nonbarbiturate hypnotic.
    DAVIS CA; GRUENER RD
    Calif Med; 1956 Apr; 84(4):290-1. PubMed ID: 13304694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and statistical evaluation of six hypnotic agents.
    le RICHE W; van BELLE
    Can Med Assoc J; 1963 Apr; 88(16):837-41. PubMed ID: 13982136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethinamate and methyprylone as hypnotics: a comparative trial.
    LODGE PATCH IC; EILENBERG MD; HARE EH
    J Ment Sci; 1960 Oct; 106():1455-8. PubMed ID: 13763022
    [No Abstract]   [Full Text] [Related]  

  • 16. Central effects of N-substituted derivatives of 2,6-dioxopiperidine in mice.
    Tateoka Y; Kimura T; Kamiyama H; Watanabe K; Yamamoto I; Ho IK
    Res Commun Chem Pathol Pharmacol; 1988 Sep; 61(3):315-26. PubMed ID: 3187198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Noludar, a new sedative].
    LANGE HJ
    Med Klin; 1956 Feb; 51(8):303-4. PubMed ID: 13308742
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolism of methyprylon.
    RANDALL LO; ILIEV V; BRANDMAN O
    Arch Int Pharmacodyn Ther; 1956 Jun; 106(4):388-94. PubMed ID: 13341134
    [No Abstract]   [Full Text] [Related]  

  • 19. Central depressant effects of methyprylon.
    KUEHN A; SCHALLEK W; SEPPELIN DK
    J Pharmacol Exp Ther; 1956 Oct; 118(2):139-47. PubMed ID: 13368050
    [No Abstract]   [Full Text] [Related]  

  • 20. METHYPRYLON.
    J Am Med Assoc; 1956 Aug; 161(14):1384. PubMed ID: 13331806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.